Asia-Pacific Injectable Drug Delivery Market Analysis, Trends & Forecast to 2025, With an Expected CAGR of 13.9% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 4, 2018--The “Asia-Pacific Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
Asia-Pacific injectable drug delivery market is expected to reach USD 220,922.25 million by 2025 from USD 67,319.56 million in 2017, at a CAGR of 13.9% in the forecast period 2018 to 2025.
The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.
The Asia-Pacific injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others.
Companies MentionedBaxter International, Inc. Becton Dickinson and Company Gerresheimer AG Pfizer, Inc. Schott AG Alkermes Plc. Eli Lilly and Company Sandoz Terumo Corporation Teva Pharmaceuticals Industries Ltd. Ypsomed Bespak
Key Topics Covered:
2 Market Segmentation
3 Market Overview
4 Executive Summary
5 Premium Insights
6 Asia-Pacific Injectable Drug Delivery Market, By Type
7 Asia-Pacific Injectable Drug Delivery Market, By Application
8 Asia-Pacific Injectable Drug Delivery Market, By Usage Pattern
9 Asia-Pacific Injectable Drug Delivery Market, By Mode Of Administration
10 Asia-Pacific Injectable Drug Delivery Market, By End User
11 Asia-Pacific Injectable Drug Delivery Market, By Distribution Channel
12 Asia-Pacific Injectable Drug Delivery Market, By Geography
13 Asia-Pacific Injectable Drug Delivery Market, Company Share
14 Company Profiles
15 Related Reports
For more information about this report visit https://www.researchandmarkets.com/research/kv2kqx/asiapacific?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180704005278/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infusions and Injectables
KEYWORD: ASIA PACIFIC
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL MEDICAL SUPPLIES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/04/2018 12:29 PM/DISC: 07/04/2018 12:29 PM